ASCO 2022: Gilead's tough weekend, bispecific progress and 'gamma delta' cell therapy
BioPharma
Stay updated with breaking news from Adicet Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MENLO PARK, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell therapies for cancer, today announced it granted inducement awards on May 31, 2022 (the “Grant Date”) under Adicet’s 2022 Inducement Plan...
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell therapies for cancer, today announced it granted inducement awards on May 31,... | June 3, 2022
The American Society of Clinical Oncology’s annual meeting begins this week, including the presentation of more than 2,800 abstracts. Amgen, Roche, and Sierra Oncology are among the companies with key presentations at this year’s gathering.
SAN FRANCISCO (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.30 A.M. ET).In the GreenPMV Pharmaceuticals, Inc. (PMVP) is up over 15%